FDA Grants Accelerated Approval to Nelkarmi (neladalkib) for Previously-Treated Advanced ALK-Positive Non-Small Cell Lung Cancer

Nov 18, 2026 - 03:00
 0  0
London, UK -- 17 November 2026 -- GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has granted accelerated approval to Nelkarmi (neladalkib) for the treatment of adults with locally advanced or metastatic anaplastic...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0